Immunologist wins 'Breakthrough Prize' for innovative cancer treatment
"Over the years, I can't tell you how many times I've heard this won't work, can't work, even if it works it has no future," the 63-year-old told AFP in an interview.
PREMIUM Health
Sadelain studied medicine in Paris, then immunology in Canada, before taking up postdoctoral research at the Massachusetts Institute of Technology in 1989.
By NewVision Reporter
Journalists @NewVision
____________________
When Michel Sadelain began his decades-long quest to genetically modify immune cells to fight cancer, his peers dismissed his ideas as absurd and even his